Merck and Bayer's heart drug vericiguat meets primary efficacy endpoint in Phase 3 study

March 28, 2020 admin Trading Ideas Comments Off on Merck and Bayer's heart drug vericiguat meets primary efficacy endpoint in Phase 3 study

…read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.